- CD8 Antibody (4B11)
- Novus Biologicals, a Bio-Techne Brand
- Pricing InfoSupplier PageView Company Product Page
- NB100-65729
- p32, CD8alpha, Leu2, CD8
- CD8 Antibody (4B11) was developed against a synthetic peptide derived from the carboxy terminal region of the human CD8 alpha chain coupled to a N-terminal cysteine, with the sequence C-KSDGKPSLSARYV. The peptide was coupled to bovine serum albuman and keyhole limpet hemocyanin
- Immunohistochemistry, Immunocytochemistry/ Immunofluorescence, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, Dual RNAscope ISH-IHC
- Tissue culture supernatant
- Unconjugated
- Human
- Monoclonal
- 4B11
- Mouse
- 0.1 ml (also 0.025 ml)
- CD8
- IgG2b
- CD8 subunit alpha
- Novus Biologicals, a Bio-Techne Brand
- Tissue culture supernatant
- 26 kDa
- Adaptive Immunity, Cancer, Cytokine Research, Immunology, Innate Immunity, Signal Transduction, Stem Cell Markers
- Primary Antibodies
- Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles
Specifications/Features
Available conjugates: Unconjugated
Specificity: CD8 Antibody (4B11) recognizes the human CD8 cell surface antigen, a 32kD glycoprotein expressed by the cytotoxic/suppressor subset of T-cells and weakly by NK cells